Skip to content

NORTHWEST BIOTHERAPEUTICS INC

NWBO

CIK 0001072379

← back to feed
Revenue (TTM)
$1.2M
−0.3% YoY Q1 May 2026
Net Income (TTM)
−$64.62M
+28.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.04
+42.9% YoY Q1 May 2026
Gross Margin
100.0%
Q1 May 2026
Operating Margin
-4,775.8%
Q1 May 2026
Net Margin
-5,384.9%
Q1 May 2026
Free Cash Flow (TTM)
−$47.17M
Q1 May 2026
Cash
$1.79M
Q1 May 2026
Total Debt
$59.49M
Q1 May 2026
Shares Outstanding
1.64B sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings